Number of the records: 1  

Cancer cells with high expression of CD133 exert FLIP upregulation and resistance to TRAIL-induced apoptosis

  1. 1.
    0340567 - BTO-N 2010 RIV NL eng J - Journal Article
    Zobalová, Renata - Stantic, M. - Prokopová, Kateřina - Dong, L. F. - Neužil, Jiří
    Cancer cells with high expression of CD133 exert FLIP upregulation and resistance to TRAIL-induced apoptosis.
    Biofactors. Roč. 34, č. 3 (2009), s. 231-235. ISSN 0951-6433
    R&D Projects: GA AV ČR(CZ) IAA500520702; GA ČR GA204/08/0811
    Institutional research plan: CEZ:AV0Z50520701
    Keywords : Cancer stem cells * CD 133 * FLIP
    Subject RIV: EB - Genetics ; Molecular Biology
    Impact factor: 0.912, year: 2009

    It is increasingly accepted that cancer stem cells (CSCs) are rather resistant to apoptosis to various inducers, including the immunological apoptogen TRAIL. Here we show that cancer cells with high expression of CD 133, a marker that is often associated with CSCs, are resistant to TRAIL-induced apoptosis, compared to their CD133-low counterparts. We show that this resistance can be ascribed to the high expression of FLIP, an inhibitor of the extrinsic apoptotic pathway, in CD133-high cells. Down¬regulation of FLIP by siRNA in CD133-high cells sensitised them to TRAIL killing. Thus, CD133-high cells may be resistant to TRAIL due to high expression of FLIP.
    Permanent Link: http://hdl.handle.net/11104/0183780